FDA Inspection 713154 — Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. — FEI 3002783962

The FDA completed an inspection of Pacira Pharmaceuticals, Inc. on January 24, 2011 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)